1. Bahar R, Zhou P, Liu Y, et al. The prevalence of anxiety and depression in patients with or without hyperhi- drosis (HH). J Am Acad Dermatol. 2016;75(6):1126-1133.
2. Hasimoto EN, Cataneo DC, dos Reis TA, Cataneo AJM. Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol. 2018;44(4):292–298. doi: 10.1590/s1806-37562017000000379.
3. Parrish C, Waldbaum B, Coleman D, Blevins C, Rodgers K, Lee B, Ober C, Hudhud L, Cox S, Griffin C, Chew S, Chen B, Brock M. Microwave Thermolysis Reduces Generalized and Social Anxiety in Young Adults With Axillary Hyperhidrosis. Lasers Surg Med. 2020 Nov;52(9):842-847. doi: 10.1002/lsm.23229. Epub 2020 Mar 16. PMID: 32175622.
4. Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010 Sep;63(3):457-65. doi: 10.1016/j.jaad.2009.09.014. Epub 2010 May 11. PMID: 20462664.
Explore Undefined Health
- Choosing a selection results in a full page refresh.
- Opens in a new window.